Advances in Therapy Pharmacology (medical)

Comparative Study Assessing Multiple Switches Between Biosimilar ABP 501 (adalimumab-atto) and Adalimumab Reference Product in Patients with Plaque Psoriasis

Paul S. Yamauchi, Vincent Chow, Daniel T. Mytych, Muhan Zhou, Waldemar Radziszewski
Springer Nature · 2026-04-09 · DOI 10.1007/s12325-026-03574-8

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →